bioMérieux: Strong start of the year driven by the US

BUY, Fair Value EUR110 (+19%)
News published on April Thursday 23, 2015
Share on

Biomérieux released Q1 results with sales up 21% on a reported basis, standing at EUR448m (vs. EUR371m in 2014). A strong currency effect of 10.1% in Q1, mainly from the US, should not overshadow robust organic growth of 8.7% over the quarter which came in higher than the confirmed 4.5-6.5% organic growth range guidance for the year. BioFire sales are up 93% at EUR37m which could help the company to surpass its annual guidance if the same growth pace is sustained throughout 2015.


For more information please contact marketing@bryangarnier.com 

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities